Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
about
Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesConsensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesisAltered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Forskolin attenuates doxorubicin-induced accumulation of asymmetric dimethylarginine and s-adenosylhomocysteine via methyltransferase activity in leukemic monocytes.
P2860
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@en
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@nl
type
label
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@en
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@nl
prefLabel
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@en
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@nl
P2093
P2860
P1476
Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.
@en
P2093
Fei-Yun Zheng
Hai-Ou Wang
Jing-Jie Zheng
P2860
P304
P356
10.3109/10641963.2015.1089880
P577
2016-05-06T00:00:00Z